Centene Corporation (CNC) has reported
strong earnings for the
third quarter of 2024 with an EPS of $1.36 and revenue of $42.0 billion, exceeding estimates. The health insurer's
low tax situation enhanced its profits. Its
subsidiary, Buckeye Health Plan, was awarded a contract to serve dual-eligible Medicare and Medicaid customers in Ohio, strengthening its strategic position. The company was named on Fortune's 100 Best Large Workplaces for Women 2024, reflecting a positive work culture. While CNC underperformed compared to its competitors, the stock is still considered a profitable
value investment. Wealth Enhancement Advisory Services LLC, Nisa Investment Advisors LLC, and other entities have a significant stake in the company. The company has issued FY 2024
earnings guidance with predictions of
long-term growth in government-sponsored healthcare. Barclays lowered Centene's share price target to $91.00 due to
Medicaid pressures adversely impacting health insurer stocks. However, according to hedge funds, CNC is a bullish health insurance stock, even amid
concerns regarding Medicaid enrollment.
Centene Corporation CNC News Analytics from Wed, 31 Jan 2024 08:00:00 GMT to Sat, 02 Nov 2024 07:54:58 GMT -
Rating 7
- Innovation 6
- Information 9
- Rumor 4
